The global market for Animal Genetic Engineering Vaccines was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 309%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Animal Genetic Engineering Vaccines, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Animal Genetic Engineering Vaccines by region & country, by Type, and by Application.
The Animal Genetic Engineering Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Genetic Engineering Vaccines.
麻豆原创 Segmentation
By Company
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
Segment by Type:
Genetic Recombinant Vaccine
Recombinant Subunit Vaccines
Genetic Vaccine
Segment by Application
Poultry
Livestock
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Genetic Engineering Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Animal Genetic Engineering Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Animal Genetic Engineering Vaccines in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 麻豆原创 Overview
1.1 Animal Genetic Engineering Vaccines Product Introduction
1.2 Global Animal Genetic Engineering Vaccines 麻豆原创 Size Forecast
1.2.1 Global Animal Genetic Engineering Vaccines Sales Value (2019-2030)
1.2.2 Global Animal Genetic Engineering Vaccines Sales Volume (2019-2030)
1.2.3 Global Animal Genetic Engineering Vaccines Sales Price (2019-2030)
1.3 Animal Genetic Engineering Vaccines 麻豆原创 Trends & Drivers
1.3.1 Animal Genetic Engineering Vaccines Industry Trends
1.3.2 Animal Genetic Engineering Vaccines 麻豆原创 Drivers & Opportunity
1.3.3 Animal Genetic Engineering Vaccines 麻豆原创 Challenges
1.3.4 Animal Genetic Engineering Vaccines 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Animal Genetic Engineering Vaccines Players Revenue Ranking (2023)
2.2 Global Animal Genetic Engineering Vaccines Revenue by Company (2019-2024)
2.3 Global Animal Genetic Engineering Vaccines Players Sales Volume Ranking (2023)
2.4 Global Animal Genetic Engineering Vaccines Sales Volume by Company Players (2019-2024)
2.5 Global Animal Genetic Engineering Vaccines Average Price by Company (2019-2024)
2.6 Key Manufacturers Animal Genetic Engineering Vaccines Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Animal Genetic Engineering Vaccines Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Animal Genetic Engineering Vaccines
2.9 Animal Genetic Engineering Vaccines 麻豆原创 Competitive Analysis
2.9.1 Animal Genetic Engineering Vaccines 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Animal Genetic Engineering Vaccines Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Animal Genetic Engineering Vaccines as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Genetic Recombinant Vaccine
3.1.2 Recombinant Subunit Vaccines
3.1.3 Genetic Vaccine
3.2 Global Animal Genetic Engineering Vaccines Sales Value by Type
3.2.1 Global Animal Genetic Engineering Vaccines Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Animal Genetic Engineering Vaccines Sales Value, by Type (2019-2030)
3.2.3 Global Animal Genetic Engineering Vaccines Sales Value, by Type (%) (2019-2030)
3.3 Global Animal Genetic Engineering Vaccines Sales Volume by Type
3.3.1 Global Animal Genetic Engineering Vaccines Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Animal Genetic Engineering Vaccines Sales Volume, by Type (2019-2030)
3.3.3 Global Animal Genetic Engineering Vaccines Sales Volume, by Type (%) (2019-2030)
3.4 Global Animal Genetic Engineering Vaccines Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Poultry
4.1.2 Livestock
4.1.3 Other
4.2 Global Animal Genetic Engineering Vaccines Sales Value by Application
4.2.1 Global Animal Genetic Engineering Vaccines Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Animal Genetic Engineering Vaccines Sales Value, by Application (2019-2030)
4.2.3 Global Animal Genetic Engineering Vaccines Sales Value, by Application (%) (2019-2030)
4.3 Global Animal Genetic Engineering Vaccines Sales Volume by Application
4.3.1 Global Animal Genetic Engineering Vaccines Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Animal Genetic Engineering Vaccines Sales Volume, by Application (2019-2030)
4.3.3 Global Animal Genetic Engineering Vaccines Sales Volume, by Application (%) (2019-2030)
4.4 Global Animal Genetic Engineering Vaccines Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Animal Genetic Engineering Vaccines Sales Value by Region
5.1.1 Global Animal Genetic Engineering Vaccines Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Animal Genetic Engineering Vaccines Sales Value by Region (2019-2024)
5.1.3 Global Animal Genetic Engineering Vaccines Sales Value by Region (2025-2030)
5.1.4 Global Animal Genetic Engineering Vaccines Sales Value by Region (%), (2019-2030)
5.2 Global Animal Genetic Engineering Vaccines Sales Volume by Region
5.2.1 Global Animal Genetic Engineering Vaccines Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Animal Genetic Engineering Vaccines Sales Volume by Region (2019-2024)
5.2.3 Global Animal Genetic Engineering Vaccines Sales Volume by Region (2025-2030)
5.2.4 Global Animal Genetic Engineering Vaccines Sales Volume by Region (%), (2019-2030)
5.3 Global Animal Genetic Engineering Vaccines Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Animal Genetic Engineering Vaccines Sales Value, 2019-2030
5.4.2 North America Animal Genetic Engineering Vaccines Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Animal Genetic Engineering Vaccines Sales Value, 2019-2030
5.5.2 Europe Animal Genetic Engineering Vaccines Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Animal Genetic Engineering Vaccines Sales Value, 2019-2030
5.6.2 Asia Pacific Animal Genetic Engineering Vaccines Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Animal Genetic Engineering Vaccines Sales Value, 2019-2030
5.7.2 South America Animal Genetic Engineering Vaccines Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Animal Genetic Engineering Vaccines Sales Value, 2019-2030
5.8.2 Middle East & Africa Animal Genetic Engineering Vaccines Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Animal Genetic Engineering Vaccines Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Animal Genetic Engineering Vaccines Sales Value
6.2.1 Key Countries/Regions Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.2.2 Key Countries/Regions Animal Genetic Engineering Vaccines Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.3.2 United States Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.4.2 Europe Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.5.2 China Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.5.3 China Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.6.2 Japan Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.7.2 South Korea Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.8.2 Southeast Asia Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Animal Genetic Engineering Vaccines Sales Value, 2019-2030
6.9.2 India Animal Genetic Engineering Vaccines Sales Value by Type (%), 2023 VS 2030
6.9.3 India Animal Genetic Engineering Vaccines Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Merck
7.1.1 Merck Company Information
7.1.2 Merck Introduction and Business Overview
7.1.3 Merck Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Merck Animal Genetic Engineering Vaccines Product Offerings
7.1.5 Merck Recent Development
7.2 GSK
7.2.1 GSK Company Information
7.2.2 GSK Introduction and Business Overview
7.2.3 GSK Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GSK Animal Genetic Engineering Vaccines Product Offerings
7.2.5 GSK Recent Development
7.3 Sanofi
7.3.1 Sanofi Company Information
7.3.2 Sanofi Introduction and Business Overview
7.3.3 Sanofi Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Sanofi Animal Genetic Engineering Vaccines Product Offerings
7.3.5 Sanofi Recent Development
7.4 Zoties
7.4.1 Zoties Company Information
7.4.2 Zoties Introduction and Business Overview
7.4.3 Zoties Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Zoties Animal Genetic Engineering Vaccines Product Offerings
7.4.5 Zoties Recent Development
7.5 Elanco
7.5.1 Elanco Company Information
7.5.2 Elanco Introduction and Business Overview
7.5.3 Elanco Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Elanco Animal Genetic Engineering Vaccines Product Offerings
7.5.5 Elanco Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Information
7.6.2 Boehringer Ingelheim Introduction and Business Overview
7.6.3 Boehringer Ingelheim Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Boehringer Ingelheim Animal Genetic Engineering Vaccines Product Offerings
7.6.5 Boehringer Ingelheim Recent Development
7.7 Indian Immunologicals
7.7.1 Indian Immunologicals Company Information
7.7.2 Indian Immunologicals Introduction and Business Overview
7.7.3 Indian Immunologicals Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Indian Immunologicals Animal Genetic Engineering Vaccines Product Offerings
7.7.5 Indian Immunologicals Recent Development
7.8 China Animal Husbandry Industry Co.,Ltd.
7.8.1 China Animal Husbandry Industry Co.,Ltd. Company Information
7.8.2 China Animal Husbandry Industry Co.,Ltd. Introduction and Business Overview
7.8.3 China Animal Husbandry Industry Co.,Ltd. Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.8.4 China Animal Husbandry Industry Co.,Ltd. Animal Genetic Engineering Vaccines Product Offerings
7.8.5 China Animal Husbandry Industry Co.,Ltd. Recent Development
7.9 Yebio Bioengineering Co., Ltd Of Qingdao
7.9.1 Yebio Bioengineering Co., Ltd Of Qingdao Company Information
7.9.2 Yebio Bioengineering Co., Ltd Of Qingdao Introduction and Business Overview
7.9.3 Yebio Bioengineering Co., Ltd Of Qingdao Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Yebio Bioengineering Co., Ltd Of Qingdao Animal Genetic Engineering Vaccines Product Offerings
7.9.5 Yebio Bioengineering Co., Ltd Of Qingdao Recent Development
7.10 Jinyu Bio-technology Co.,ltd.
7.10.1 Jinyu Bio-technology Co.,ltd. Company Information
7.10.2 Jinyu Bio-technology Co.,ltd. Introduction and Business Overview
7.10.3 Jinyu Bio-technology Co.,ltd. Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Jinyu Bio-technology Co.,ltd. Animal Genetic Engineering Vaccines Product Offerings
7.10.5 Jinyu Bio-technology Co.,ltd. Recent Development
7.11 HVRI
7.11.1 HVRI Company Information
7.11.2 HVRI Introduction and Business Overview
7.11.3 HVRI Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.11.4 HVRI Animal Genetic Engineering Vaccines Product Offerings
7.11.5 HVRI Recent Development
7.12 Ringpu Biology
7.12.1 Ringpu Biology Company Information
7.12.2 Ringpu Biology Introduction and Business Overview
7.12.3 Ringpu Biology Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Ringpu Biology Animal Genetic Engineering Vaccines Product Offerings
7.12.5 Ringpu Biology Recent Development
7.13 Kyoto Biken Laboratories
7.13.1 Kyoto Biken Laboratories Company Information
7.13.2 Kyoto Biken Laboratories Introduction and Business Overview
7.13.3 Kyoto Biken Laboratories Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Kyoto Biken Laboratories Animal Genetic Engineering Vaccines Product Offerings
7.13.5 Kyoto Biken Laboratories Recent Development
7.14 FATRO
7.14.1 FATRO Company Information
7.14.2 FATRO Introduction and Business Overview
7.14.3 FATRO Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.14.4 FATRO Animal Genetic Engineering Vaccines Product Offerings
7.14.5 FATRO Recent Development
7.15 Ceva Sant茅 Animale
7.15.1 Ceva Sant茅 Animale Company Information
7.15.2 Ceva Sant茅 Animale Introduction and Business Overview
7.15.3 Ceva Sant茅 Animale Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Ceva Sant茅 Animale Animal Genetic Engineering Vaccines Product Offerings
7.15.5 Ceva Sant茅 Animale Recent Development
7.16 Pulike Biological Engineering,Inc.
7.16.1 Pulike Biological Engineering,Inc. Company Information
7.16.2 Pulike Biological Engineering,Inc. Introduction and Business Overview
7.16.3 Pulike Biological Engineering,Inc. Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Pulike Biological Engineering,Inc. Animal Genetic Engineering Vaccines Product Offerings
7.16.5 Pulike Biological Engineering,Inc. Recent Development
7.17 Wuhan Hvsen Biotechnology CO.,LTD
7.17.1 Wuhan Hvsen Biotechnology CO.,LTD Company Information
7.17.2 Wuhan Hvsen Biotechnology CO.,LTD Introduction and Business Overview
7.17.3 Wuhan Hvsen Biotechnology CO.,LTD Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.17.4 Wuhan Hvsen Biotechnology CO.,LTD Animal Genetic Engineering Vaccines Product Offerings
7.17.5 Wuhan Hvsen Biotechnology CO.,LTD Recent Development
7.18 Jinhe Biotechnology Co., Ltd.
7.18.1 Jinhe Biotechnology Co., Ltd. Company Information
7.18.2 Jinhe Biotechnology Co., Ltd. Introduction and Business Overview
7.18.3 Jinhe Biotechnology Co., Ltd. Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.18.4 Jinhe Biotechnology Co., Ltd. Animal Genetic Engineering Vaccines Product Offerings
7.18.5 Jinhe Biotechnology Co., Ltd. Recent Development
7.19 Shanghai Shen Lian Biomedical Corporation
7.19.1 Shanghai Shen Lian Biomedical Corporation Company Information
7.19.2 Shanghai Shen Lian Biomedical Corporation Introduction and Business Overview
7.19.3 Shanghai Shen Lian Biomedical Corporation Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.19.4 Shanghai Shen Lian Biomedical Corporation Animal Genetic Engineering Vaccines Product Offerings
7.19.5 Shanghai Shen Lian Biomedical Corporation Recent Development
7.20 Qingdao Vland Biotech INC.
7.20.1 Qingdao Vland Biotech INC. Company Information
7.20.2 Qingdao Vland Biotech INC. Introduction and Business Overview
7.20.3 Qingdao Vland Biotech INC. Animal Genetic Engineering Vaccines Sales, Revenue and Gross Margin (2019-2024)
7.20.4 Qingdao Vland Biotech INC. Animal Genetic Engineering Vaccines Product Offerings
7.20.5 Qingdao Vland Biotech INC. Recent Development
8 Industry Chain Analysis
8.1 Animal Genetic Engineering Vaccines Industrial Chain
8.2 Animal Genetic Engineering Vaccines Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Animal Genetic Engineering Vaccines Sales Model
8.5.2 Sales Channel
8.5.3 Animal Genetic Engineering Vaccines Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Merck
GSK
Sanofi
Zoties
Elanco
Boehringer Ingelheim
Indian Immunologicals
China Animal Husbandry Industry Co.,Ltd.
Yebio Bioengineering Co., Ltd Of Qingdao
Jinyu Bio-technology Co.,ltd.
HVRI
Ringpu Biology
Kyoto Biken Laboratories
FATRO
Ceva Sant茅 Animale
Pulike Biological Engineering,Inc.
Wuhan Hvsen Biotechnology CO.,LTD
Jinhe Biotechnology Co., Ltd.
Shanghai Shen Lian Biomedical Corporation
Qingdao Vland Biotech INC.
听
听
*If Applicable.